BioCentury
ARTICLE | Distillery Techniques

Techniques: Serotonin (5-HT1A) receptor-targeting PET imaging agent for diagnosis and stratification of early Parkinson's disease (PD)

March 17, 2016 7:00 AM UTC

A serotonin (5-HT1A) receptor-targeting PET imaging agent could help diagnose early PD and stratify PD patients for clinical trials. Postmortem brain tissue analyses have found high levels of 5-HT1A r...